Latest Regulatory Challenges News

Nyrada has dosed the first patient in its Phase IIa trial of Xolatryp targeting heart attack recovery, while strengthening its cash reserves and receiving a US patent allowance for its lead drug.

The Star Entertainment Group reported a significant improvement in quarterly EBITDA loss alongside stable revenue, completing key joint venture exit and refinancing milestones that boosted liquidity to $267 million.

Macquarie Group reports a 30% profit increase in FY26 to A$4.85 billion as CEO Shemara Wikramanayake announces retirement, with Greg Ward set to take the helm in November 2026.

Vysarn Limited reported a record FY26 with NPBT of $20.9 million and operational revenue of $140.1 million, while completing the $50 million NewGround acquisition that boosts pro forma EPS by 26.7%.

Kingfish Limited outperformed the S&P/NZX50G with an 8.7% gross portfolio return in Q2 2026, driven by strong results from Fisher & Paykel Healthcare, Vista Group, and Infratil, while a2 Milk faced supply chain and regulatory challenges.

Richmond Vanadium Technology has appointed Seth McCann as General Manager for Development, Approvals & Studies, positioning the company to advance critical environmental and regulatory milestones for its Queensland vanadium project.

Vectus Biosystems has appointed Cardinal Health Regulatory Services as its US regulatory agent to manage FDA submissions for its lead fibrosis drug VB0004, marking a pivotal step towards clinical development in the US.

Mayfield Childcare has pulled its FY26 earnings guidance amid rising costs and regulatory shifts, while cautiously advancing its Mayfield 360 allied health initiative.

PEXA faces a proposed 20% cut in regulated ELNO service fees, risking a $70 million revenue reduction over a year. The company urges a phased approach to mitigate business impact as IPART opens public consultation.

Neuren’s partner Acadia secures positive CHMP opinion for DAYBU® in Rett syndrome, paving the way for first EU treatment approval and triggering significant milestone payments for Neuren.

Sequoia Financial Group has postponed its dividend payment from late June to late August following ASIC's directive tied to ongoing Federal Court proceedings over the InterPrac sale.

Kingston Resources launches a $8.47 million rights issue at a 12.5% discount, backed by a $4.4 million placement, to finance a major drilling campaign and plant expansion at Mineral Hill following the closure of its Pearse South open pit.